NEW YORK (GenomeWeb News) — French in vitro diagnostics firm BioMérieux said today that it has entered into an agreement to acquire BioFire Diagnostics for $450 million plus BioFire's net financial debt.

BioFire, which until August 2012 was known as Idaho Technology, is based in Salt Lake City, Utah, and markets the FilmArray molecular diagnostics system and associated syndromic infectious disease assay panels.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: The sea anemone is sequenced, a team describes a CRISPR/Cas9-based approach to label specific sites in the genome, and more. 

In a short video, CNN introduces viewers to a fecal transplant poop donor and explains how the treatments are made.

Researchers are testing the use of transgenically altered diamondback moths as an alternative to pesticides in controlling the bugs.

Two recent papers published in Science and Nature Medicine describe work that may result in a universal vaccine for the flu.